14.09.2009
omówienie artykułu: Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age
D. Lewis, P. Winner, J. Saper, S. Ness, E. Polverejan, S. Wang, C.L. Kurland, J. Nye, E. Yuen, M. Eerdekens, L. Ford
Pediatrics, 2009; 123: 924–934